- Published on
KembaraXtra- Medicine – Atrial Flutter
Typical atrial flutter is a stable macroreentrant atrial rhythm that circulates around the tricuspid annulus in the right atrium. The critical component of this circuit is the cavotricuspid isthmus (CTI), the tissue between the inferior vena cava and the tricuspid valve, which is why typical flutter is also referred to as CTI-dependent atrial flutter. Because the circuit is anatomically and physiologically stable, atrial depolarization is regular, usually occurring at a rate of 250–350 beats per minute.
Atypical atrial flutter refers to regular macroreentrant atrial tachyarrhythmias that do not depend on the CTI. These forms often occur after cardiac surgery, in patients with congenital heart disease, or following catheter ablation procedures—particularly left atrial ablation for atrial fibrillation—although they may also occur without an identifiable cause.
Conduction through the atrioventricular (AV) node in atrial flutter often follows predictable ratios. For example, with an atrial rate of 300 beats per minute, 2:1 AV conduction produces a ventricular rate of about 150 beats per minute, while 3:1 and 4:1 conduction produce ventricular rates of approximately 100 and 75 beats per minute, respectively. When AV nodal conduction varies, the ventricular rhythm may appear irregular, although a consistent atrial cycle length is often still present.
Atrial flutter is the second most common sustained atrial tachyarrhythmia after atrial fibrillation, with an estimated 200,000 new cases each year in the United States. Its prevalence increases with age and is about 2.5 times more common in men than in women. It is frequently seen in patients with congestive heart failure, chronic obstructive pulmonary disease, pulmonary embolism, pulmonary hypertension, or in the early postoperative period following open-heart surgery. Importantly, more than half of patients with atrial flutter will develop atrial fibrillation within three years, and more than 80% within five years.
Clinically, atrial flutter may present with palpitations, dizziness, light-headedness, syncope or near syncope, chest pain, dyspnea, or worsening heart failure. Some patients develop thromboembolic complications due to intracardiac thrombus formation. Common etiologic associations include age-related atrial degeneration, rheumatic or congenital heart disease, ventricular dysfunction, mitral valve disease, thyrotoxicosis, pulmonary embolism, obesity, pericarditis, and prior cardiac surgery. Antiarrhythmic therapy for atrial fibrillation may also predispose patients to developing atrial flutter.
Diagnosis is primarily established by electrocardiography. Typical findings include absence of normal P waves and the presence of regular “sawtooth” flutter waves without an isoelectric baseline, most clearly seen in the inferior leads (II, III, and aVF). Atrioventricular conduction is usually 2:1, 3:1, or 4:1 rather than 1:1, unless pre-excitation is present. Holter or event monitoring may be useful for intermittent symptoms or to assess rate control. Echocardiography is recommended in newly diagnosed patients to evaluate for structural heart disease, and transesophageal echocardiography may be required to exclude atrial thrombus before cardioversion. Electrophysiologic studies are used for definitive diagnosis and for catheter ablation therapy.
Typical atrial flutter is a stable macroreentrant atrial rhythm that circulates around the tricuspid annulus in the right atrium. The critical component of this circuit is the cavotricuspid isthmus (CTI), the tissue between the inferior vena cava and the tricuspid valve, which is why typical flutter is also referred to as CTI-dependent atrial flutter. Because the circuit is anatomically and physiologically stable, atrial depolarization is regular, usually occurring at a rate of 250–350 beats per minute.
Atypical atrial flutter refers to regular macroreentrant atrial tachyarrhythmias that do not depend on the CTI. These forms often occur after cardiac surgery, in patients with congenital heart disease, or following catheter ablation procedures—particularly left atrial ablation for atrial fibrillation—although they may also occur without an identifiable cause.
Conduction through the atrioventricular (AV) node in atrial flutter often follows predictable ratios. For example, with an atrial rate of 300 beats per minute, 2:1 AV conduction produces a ventricular rate of about 150 beats per minute, while 3:1 and 4:1 conduction produce ventricular rates of approximately 100 and 75 beats per minute, respectively. When AV nodal conduction varies, the ventricular rhythm may appear irregular, although a consistent atrial cycle length is often still present.
Atrial flutter is the second most common sustained atrial tachyarrhythmia after atrial fibrillation, with an estimated 200,000 new cases each year in the United States. Its prevalence increases with age and is about 2.5 times more common in men than in women. It is frequently seen in patients with congestive heart failure, chronic obstructive pulmonary disease, pulmonary embolism, pulmonary hypertension, or in the early postoperative period following open-heart surgery. Importantly, more than half of patients with atrial flutter will develop atrial fibrillation within three years, and more than 80% within five years.
Clinically, atrial flutter may present with palpitations, dizziness, light-headedness, syncope or near syncope, chest pain, dyspnea, or worsening heart failure. Some patients develop thromboembolic complications due to intracardiac thrombus formation. Common etiologic associations include age-related atrial degeneration, rheumatic or congenital heart disease, ventricular dysfunction, mitral valve disease, thyrotoxicosis, pulmonary embolism, obesity, pericarditis, and prior cardiac surgery. Antiarrhythmic therapy for atrial fibrillation may also predispose patients to developing atrial flutter.
Diagnosis is primarily established by electrocardiography. Typical findings include absence of normal P waves and the presence of regular “sawtooth” flutter waves without an isoelectric baseline, most clearly seen in the inferior leads (II, III, and aVF). Atrioventricular conduction is usually 2:1, 3:1, or 4:1 rather than 1:1, unless pre-excitation is present. Holter or event monitoring may be useful for intermittent symptoms or to assess rate control. Echocardiography is recommended in newly diagnosed patients to evaluate for structural heart disease, and transesophageal echocardiography may be required to exclude atrial thrombus before cardioversion. Electrophysiologic studies are used for definitive diagnosis and for catheter ablation therapy.
0 Comments
